Error: Error validating access token: Session has expired on Sunday, 10-Feb-19 12:04:01 PST. The current time is Friday, 22-Feb-19 08:49:25 PST. Type: OAuthException Code: 190 Subcode: 463 Please refer to our Error Message Reference.
BREAKTHROUGH DESIGNATION FROM FDA | TK2 DEFICIENCY TREATMENT
Modis Therapeutics announced the FDA has granted Breakthrough Therapy designation to MT1621, Modis' investigational treatment for patients with thymidine kinase 2 deficiency (TK2d). To read... https://t.co/p2VTPBE6GS
MitoCanada Foundation is a federally incorporated not for profit organization. Charitable Registration Number: 81258 6667 RR0001
Please note: This site does not provide medical advice. The contents of this site are for information purposes only and are not in any way intended to replace or substitute for the advice of your healthcare professional. Your own healthcare professional is the best source of information regarding your health.